Thompson Davis & CO. Inc. Grows Position in Profound Medical Corp. (NASDAQ:PROF)

Thompson Davis & CO. Inc. boosted its holdings in Profound Medical Corp. (NASDAQ:PROF) by 36.2% in the third quarter, Holdings Channel.com reports. The institutional investor owned 101,900 shares of the company’s stock after acquiring an additional 27,100 shares during the period. Profound Medical makes up 0.6% of Thompson Davis & CO. Inc.’s portfolio, making the stock its 26th largest holding. Thompson Davis & CO. Inc.’s holdings in Profound Medical were worth $811,000 as of its most recent SEC filing.

Separately, Raymond James Trust N.A. purchased a new stake in Profound Medical during the 2nd quarter valued at $88,000. 47.86% of the stock is currently owned by institutional investors.

Profound Medical Stock Down 0.1 %

PROF opened at $7.83 on Wednesday. Profound Medical Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.69. The company has a debt-to-equity ratio of 0.11, a quick ratio of 5.16 and a current ratio of 6.12. The stock has a market cap of $193.10 million, a price-to-earnings ratio of -5.84 and a beta of 0.83. The firm’s fifty day moving average is $7.76 and its 200 day moving average is $8.47.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Lake Street Capital assumed coverage on Profound Medical in a research report on Tuesday, July 23rd. They set a “buy” rating and a $16.50 price objective for the company. Raymond James raised shares of Profound Medical to a “strong-buy” rating in a report on Saturday, November 9th.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.